Karyopharm Therapeutics Inc. Income Tax Expense
Karyopharm Therapeutics Inc. (KPTI) reported Income Tax Expense of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxExpenseBenefit · last filed 2026-08-13
- Karyopharm Therapeutics Inc. income tax expense (benefit) for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- Karyopharm Therapeutics Inc. income tax expense (benefit) for the quarter ending 2026-03-31 was $1.00K, a 97.22% decline year-over-year.
- Karyopharm Therapeutics Inc. income tax expense (benefit) for the quarter ending 2025-12-31 was -$67.00K.
- Karyopharm Therapeutics Inc. income tax expense (benefit) for the quarter ending 2025-09-30 was $34.00K, a 21.43% increase year-over-year.
- Karyopharm Therapeutics Inc. income tax expense (benefit) for fiscal 2025 was $43.00K, a 24.56% decline from fiscal 2024.
- Karyopharm Therapeutics Inc. income tax expense (benefit) for fiscal 2024 was $57.00K, a 82.35% decline from fiscal 2023.
- Karyopharm Therapeutics Inc. income tax expense (benefit) for fiscal 2023 was $323.00K, a 12.47% decline from fiscal 2022.
- Karyopharm Therapeutics Inc. income tax expense (benefit) for fiscal 2022 was $369.00K, a 37.69% increase from fiscal 2021.
| Period end | Income Tax Expense (Benefit) 3 month | Income Tax Expense (Benefit) 6 month | Income Tax Expense (Benefit) 9 month | Income Tax Expense (Benefit) 12 month | Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-13 | $1.00K 10-Q · filed 2026-08-13 | -$66.00K derived: sum of 3 quarters · filed 2026-08-13 | -$32.00K derived: sum of 4 quarters · filed 2026-08-13 | |
| 2026-03-31 | $1.00K 10-Q · filed 2026-05-14 | -$66.00K derived: sum of 2 quarters · filed 2026-05-14 | -$32.00K derived: sum of 3 quarters · filed 2026-05-14 | $8.00K derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-12-31 | -$67.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | -$33.00K derived: sum of 2 quarters · filed 2026-02-13 | $7.00K derived: sum of 3 quarters · filed 2026-08-13 | $43.00K 10-K · filed 2026-02-13 | |
| 2025-09-30 | $34.00K 10-Q · filed 2025-11-03 | $74.00K derived: sum of 2 quarters · filed 2026-08-13 | $110.00K 10-Q · filed 2025-11-03 | $1.00K derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-06-30 | $40.00K 10-Q · filed 2026-08-13 | $76.00K 10-Q · filed 2026-08-13 | -$33.00K derived: sum of 3 quarters · filed 2026-08-13 | -$5.00K derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-03-31 | $36.00K 10-Q · filed 2026-05-14 | -$73.00K derived: sum of 2 quarters · filed 2026-05-14 | -$45.00K derived: sum of 3 quarters · filed 2026-05-14 | $22.00K derived: sum of 4 quarters · filed 2026-05-14 | |
| 2024-12-31 | -$109.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | -$81.00K derived: sum of 2 quarters · filed 2026-02-13 | -$14.00K derived: sum of 3 quarters · filed 2026-02-13 | $57.00K 10-K · filed 2026-02-13 | |
| 2024-09-30 | $28.00K 10-Q · filed 2025-11-03 | $95.00K derived: sum of 2 quarters · filed 2025-11-03 | $166.00K 10-Q · filed 2025-11-03 | $296.00K derived: sum of 4 quarters · filed 2026-02-13 | |
| 2024-06-30 | $67.00K 10-Q · filed 2025-08-11 | $138.00K 10-Q · filed 2025-08-11 | $268.00K derived: sum of 3 quarters · filed 2026-02-13 | $280.00K derived: sum of 4 quarters · filed 2026-02-13 | |
| 2024-03-31 | $71.00K 10-Q · filed 2025-05-12 | $201.00K derived: sum of 2 quarters · filed 2026-02-13 | $213.00K derived: sum of 3 quarters · filed 2026-02-13 | $340.00K derived: sum of 4 quarters · filed 2026-02-13 | |
| 2023-12-31 | $130.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $142.00K derived: sum of 2 quarters · filed 2026-02-13 | $269.00K derived: sum of 3 quarters · filed 2026-02-13 | $323.00K 10-K · filed 2026-02-13 | |
| 2023-09-30 | $12.00K 10-Q · filed 2024-11-05 | $139.00K derived: sum of 2 quarters · filed 2024-11-05 | $193.00K 10-Q · filed 2024-11-05 | $266.00K derived: sum of 4 quarters · filed 2025-02-19 | |
| 2023-06-30 | $127.00K 10-Q · filed 2024-08-06 | $181.00K 10-Q · filed 2024-08-06 | $254.00K derived: sum of 3 quarters · filed 2025-02-19 | $299.00K derived: sum of 4 quarters · filed 2025-02-19 | |
| 2023-03-31 | $54.00K 10-Q · filed 2024-05-08 | $127.00K derived: sum of 2 quarters · filed 2025-02-19 | $172.00K derived: sum of 3 quarters · filed 2025-02-19 | $293.00K derived: sum of 4 quarters · filed 2025-02-19 | |
| 2022-12-31 | $73.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-19 | $118.00K derived: sum of 2 quarters · filed 2025-02-19 | $239.00K derived: sum of 3 quarters · filed 2025-02-19 | $369.00K 10-K · filed 2025-02-19 | |
| 2022-09-30 | $45.00K 10-Q · filed 2023-11-02 | $166.00K derived: sum of 2 quarters · filed 2023-11-02 | $296.00K 10-Q · filed 2023-11-02 | $175.00K derived: sum of 4 quarters · filed 2024-02-29 | |
| 2022-06-30 | $121.00K 10-Q · filed 2023-08-02 | $251.00K 10-Q · filed 2023-08-02 | $130.00K derived: sum of 3 quarters · filed 2024-02-29 | $236.00K derived: sum of 4 quarters · filed 2024-02-29 | |
| 2022-03-31 | $130.00K 10-Q · filed 2023-05-04 | $9.00K derived: sum of 2 quarters · filed 2024-02-29 | $115.00K derived: sum of 3 quarters · filed 2024-02-29 | $249.00K derived: sum of 4 quarters · filed 2024-02-29 | |
| 2021-12-31 | -$121.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$15.00K derived: sum of 2 quarters · filed 2024-02-29 | $119.00K derived: sum of 3 quarters · filed 2024-02-29 | $268.00K 10-K · filed 2024-02-29 | |
| 2021-09-30 | $106.00K 10-Q · filed 2022-11-03 | $240.00K derived: sum of 2 quarters · filed 2022-11-03 | $389.00K 10-Q · filed 2022-11-03 | $451.00K derived: sum of 4 quarters · filed 2023-02-17 | |
| 2021-06-30 | $134.00K 10-Q · filed 2022-08-04 | $283.00K 10-Q · filed 2022-08-04 | $345.00K derived: sum of 3 quarters · filed 2023-02-17 | $389.00K derived: sum of 4 quarters · filed 2023-02-17 | |
| 2021-03-31 | $149.00K 10-Q · filed 2022-05-05 | $211.00K derived: sum of 2 quarters · filed 2023-02-17 | $255.00K derived: sum of 3 quarters · filed 2023-02-17 | $392.00K derived: sum of 4 quarters · filed 2023-02-17 | |
| 2020-12-31 | $62.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-17 | $106.00K derived: sum of 2 quarters · filed 2023-02-17 | $243.00K derived: sum of 3 quarters · filed 2023-02-17 | $309.00K 10-K · filed 2023-02-17 | |
| 2020-09-30 | $44.00K 10-Q · filed 2021-11-03 | $181.00K derived: sum of 2 quarters · filed 2021-11-03 | $247.00K 10-Q · filed 2021-11-03 | $249.00K derived: sum of 4 quarters · filed 2022-03-01 | |
| 2020-06-30 | $137.00K 10-Q · filed 2021-08-05 | $203.00K 10-Q · filed 2021-08-05 | $205.00K derived: sum of 3 quarters · filed 2022-03-01 | $225.00K derived: sum of 4 quarters · filed 2022-03-01 | |
| 2020-03-31 | $66.00K 10-Q · filed 2021-05-04 | $68.00K derived: sum of 2 quarters · filed 2022-03-01 | $88.00K derived: sum of 3 quarters · filed 2022-03-01 | $96.00K derived: sum of 4 quarters · filed 2022-03-01 | |
| 2019-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $22.00K derived: sum of 2 quarters · filed 2022-03-01 | $30.00K derived: sum of 3 quarters · filed 2022-03-01 | $40.00K 10-K · filed 2022-03-01 | |
| 2019-09-30 | $20.00K 10-Q · filed 2020-11-02 | $28.00K derived: sum of 2 quarters · filed 2020-11-02 | $38.00K 10-Q · filed 2020-11-02 | $55.00K derived: sum of 4 quarters · filed 2021-02-24 | |
| 2019-06-30 | $8.00K 10-Q · filed 2020-08-04 | $18.00K 10-Q · filed 2020-08-04 | $35.00K derived: sum of 3 quarters · filed 2021-02-24 | $49.00K derived: sum of 4 quarters · filed 2021-02-24 | |
| 2019-03-31 | $10.00K 10-Q · filed 2020-05-05 | $27.00K derived: sum of 2 quarters · filed 2021-02-24 | $41.00K derived: sum of 3 quarters · filed 2021-02-24 | $24.00K derived: sum of 4 quarters · filed 2021-02-24 | |
| 2018-12-31 | $17.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $31.00K derived: sum of 2 quarters · filed 2021-02-24 | $14.00K derived: sum of 3 quarters · filed 2021-02-24 | $26.00K 10-K · filed 2021-02-24 | |
| 2018-09-30 | $14.00K 10-Q · filed 2019-11-04 | -$3.00K derived: sum of 2 quarters · filed 2019-11-04 | $9.00K 10-Q · filed 2019-11-04 | $18.00K derived: sum of 4 quarters · filed 2020-02-26 | |
| 2018-06-30 | -$17.00K 10-Q · filed 2019-08-07 | -$5.00K 10-Q · filed 2019-08-07 | $4.00K derived: sum of 3 quarters · filed 2020-02-26 | $17.00K derived: sum of 4 quarters · filed 2020-02-26 | |
| 2018-03-31 | $12.00K 10-Q · filed 2019-05-09 | $21.00K derived: sum of 2 quarters · filed 2020-02-26 | $34.00K derived: sum of 3 quarters · filed 2020-02-26 | $52.00K derived: sum of 4 quarters · filed 2020-02-26 | |
| 2017-12-31 | $9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | $22.00K derived: sum of 2 quarters · filed 2020-02-26 | $40.00K derived: sum of 3 quarters · filed 2020-02-26 | $63.00K 10-K · filed 2020-02-26 | |
| 2017-09-30 | $13.00K 10-Q · filed 2018-11-08 | $31.00K derived: sum of 2 quarters · filed 2018-11-08 | $54.00K 10-Q · filed 2018-11-08 | ||
| 2017-06-30 | $18.00K 10-Q · filed 2018-08-07 | $41.00K 10-Q · filed 2018-08-07 | |||
| 2017-03-31 | $23.00K 10-Q · filed 2018-05-10 | ||||
| 2016-12-31 | $139.00K 10-K · filed 2019-02-28 | ||||
| 2015-12-31 | -$118.08M 10-K · filed 2016-03-15 | ||||
| 2014-12-31 | -$75.78M 10-K · filed 2016-03-15 | -$76.33M 10-K · filed 2015-03-13 | |||
| 2013-12-31 | -$33.95M 10-K · filed 2016-03-15 | ||||
| 2012-12-31 | -$15.89M 10-K · filed 2015-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |